s6y
Company name or ticker
Search
Allogene Therapeutics, Inc.
3
Mayo Stephen: Initial statement of beneficial ownership of securities
Filed
Tuesday, July 12, 2022
Period
Jul 8, 2022
Accession number
0001737287-22-000052
Documents
PRIMARY DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header